• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

洞察葡萄牙感染性心内膜炎的流行病学:一项2010年至2018年的当代全国性研究。

Insight into the epidemiology of infective endocarditis in Portugal: a contemporary nationwide study from 2010 to 2018.

作者信息

Sousa Catarina, Nogueira Paulo, Pinto Fausto J

机构信息

Centro Cardiovascular da Universidade de Lisboa (CCUL), Centro Académico de Medicina de Lisboa (CAML), Faculdade de Medicina da Universidade de Lisboa, Av. Prof. Egas Moniz MB, 1649-028, Lisbon, Portugal.

Serviço de Cardiologia, Centro Hospitalar Barreiro Montijo (CHBM), EPE, Barreiro, Portugal.

出版信息

BMC Cardiovasc Disord. 2021 Mar 16;21(1):138. doi: 10.1186/s12872-021-01937-3.

DOI:10.1186/s12872-021-01937-3
PMID:33726669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7962378/
Abstract

BACKGROUND

Nationwide hospital admissions data series have contributed to a reliable assessment of the changing epidemiology of infective endocarditis, even though conclusions are not uniform. We sought to use a recent populational series to describe the temporal trends on the incidence of infective endocarditis, its clinical characteristics and outcome results, in Portugal.

METHODS

A nationwide retrospective temporal trend study on the incidence and clinical characterization of patients hospitalized with infective endocarditis, between 2010 and 2018.

RESULTS

7574 patients were hospitalized with infective endocarditis from 2010 to 2018 in Portuguese public hospitals. The average length of hospitalization was 29.3 ± 28.7 days, predominantly men (56.9%), and 47.1% had between 60 and 79 years old. The most frequent infectious agents involved were Staphylococcus (16.4%) and Streptococcus (13.6%). During hospitalization, 12.4% of patients underwent heart valve surgery and 20% of the total cohort died. After a 1-year post-discharge follow-up, 13.2% of the total initial cohort had had heart valve surgery and 21.2% in total died. The annual incidence of infective endocarditis was 8.31 per 100,000 habitants, being higher in men (9.96 per 100,000 in males versus 6.82 in females, p < 0.001) and increased with age, peaking at patients 80 years old or older (40.62 per 100,000). In-hospital mortality rate significantly increased during the analyzed period, the strongest independent predictors being ischemic or hemorrhagic stroke, sepsis, and acute renal failure. Younger age and cardiac surgery had a protective effect towards a fatal outcome.

CONCLUSIONS

In Portugal, between 2010 and 2018, the incidence of infective endocarditis presented a general growth trend with a deceleration in the most recent years. Also, a significant rate of in-hospital complications, a mildly lower than expected stable surgical rate and a still high and growing mortality rate were noted.

摘要

背景

尽管结论并不统一,但全国性的医院入院数据系列有助于对感染性心内膜炎不断变化的流行病学进行可靠评估。我们试图利用最近的一个人群系列来描述葡萄牙感染性心内膜炎发病率的时间趋势、其临床特征和预后结果。

方法

对2010年至2018年期间因感染性心内膜炎住院患者的发病率和临床特征进行全国性回顾性时间趋势研究。

结果

2010年至2018年期间,7574例患者因感染性心内膜炎在葡萄牙公立医院住院。平均住院时间为29.3±28.7天,以男性为主(56.9%),47.1%的患者年龄在60至79岁之间。最常见的感染病原体是葡萄球菌(16.4%)和链球菌(13.6%)。住院期间,12.4%的患者接受了心脏瓣膜手术,总队列中有20%的患者死亡。出院后1年随访时,初始队列中有13.2%的患者接受了心脏瓣膜手术,总共有21.2%的患者死亡。感染性心内膜炎的年发病率为每10万居民8.31例,男性发病率更高(男性为每10万居民9.96例,女性为6.82例,p<0.001),且随年龄增长而增加,在80岁及以上患者中达到峰值(每10万居民40.62例)。在分析期间,住院死亡率显著增加,最强的独立预测因素是缺血性或出血性中风、败血症和急性肾衰竭。年轻和心脏手术对致命结局有保护作用。

结论

在葡萄牙,2010年至2018年期间,感染性心内膜炎的发病率总体呈增长趋势,最近几年有所放缓。此外,还注意到住院并发症发生率较高、手术率略低于预期且稳定、死亡率仍然很高且呈上升趋势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a0/7962378/bddcd416839c/12872_2021_1937_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a0/7962378/ee54372e8d92/12872_2021_1937_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a0/7962378/a2482b940617/12872_2021_1937_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a0/7962378/bddcd416839c/12872_2021_1937_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a0/7962378/ee54372e8d92/12872_2021_1937_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a0/7962378/a2482b940617/12872_2021_1937_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a0/7962378/bddcd416839c/12872_2021_1937_Fig3_HTML.jpg

相似文献

1
Insight into the epidemiology of infective endocarditis in Portugal: a contemporary nationwide study from 2010 to 2018.洞察葡萄牙感染性心内膜炎的流行病学:一项2010年至2018年的当代全国性研究。
BMC Cardiovasc Disord. 2021 Mar 16;21(1):138. doi: 10.1186/s12872-021-01937-3.
2
Infective Endocarditis as the Cause of Death: A Populationbased Study in Portugal, from 2002 to 2018.感染性心内膜炎致死原因:2002 年至 2018 年葡萄牙基于人群的研究。
Acta Med Port. 2021 Dec 2;34(12):833-841. doi: 10.20344/amp.14609. Epub 2021 Mar 8.
3
Trends, microbiology, and outcomes of infective endocarditis in children during 2000-2010 in the United States.2000 - 2010年美国儿童感染性心内膜炎的趋势、微生物学及转归
Congenit Heart Dis. 2017 Mar;12(2):196-201. doi: 10.1111/chd.12425. Epub 2016 Nov 25.
4
The burden of infective endocarditis in Portugal in the last 30 years - a systematic review of observational studies.过去 30 年葡萄牙感染性心内膜炎负担的系统评价:观察性研究。
Rev Port Cardiol (Engl Ed). 2021 Mar;40(3):205-217. doi: 10.1016/j.repc.2020.07.014. Epub 2021 Feb 27.
5
Epidemiology and risk factors of infective endocarditis in a tertiary hospital in China from 2007 to 2016.2007 年至 2016 年中国一家三级医院感染性心内膜炎的流行病学和危险因素。
BMC Infect Dis. 2020 Jun 18;20(1):428. doi: 10.1186/s12879-020-05153-w.
6
Temporal trends in incidence, patient characteristics, microbiology and in-hospital mortality in patients with infective endocarditis: a contemporary analysis of 86,469 cases between 2007 and 2019.2007 年至 2019 年期间 86469 例感染性心内膜炎患者的发病率、患者特征、微生物学和住院死亡率的时间趋势:当代分析。
Clin Res Cardiol. 2024 Feb;113(2):205-215. doi: 10.1007/s00392-022-02100-4. Epub 2022 Sep 12.
7
Incidence, Predictors, and Outcomes of Endocarditis After Transcatheter Aortic Valve Replacement in the United States.美国经导管主动脉瓣置换术后心内膜炎的发生率、预测因素和结局。
JACC Cardiovasc Interv. 2020 Sep 14;13(17):1973-1982. doi: 10.1016/j.jcin.2020.05.012.
8
Trends in occurrence and 30-day mortality of infective endocarditis in adults: population-based registry study in Finland.成人感染性心内膜炎发病和 30 天死亡率趋势:芬兰基于人群的注册研究。
BMJ Open. 2019 Apr 20;9(4):e026811. doi: 10.1136/bmjopen-2018-026811.
9
Incidence and outcome of Staphylococcus aureus endocarditis--a 10-year single-centre northern European experience.金黄色葡萄球菌心内膜炎的发生率和结局——一项 10 年北欧单中心经验。
Clin Microbiol Infect. 2015 Aug;21(8):772-8. doi: 10.1016/j.cmi.2015.04.014. Epub 2015 Apr 28.
10
Infective endocarditis post-transcatheter aortic valve implantation (TAVI), microbiological profile and clinical outcomes: A systematic review.经导管主动脉瓣植入术后感染性心内膜炎(TAVI)的微生物学特征和临床结局:系统评价。
PLoS One. 2020 Jan 17;15(1):e0225077. doi: 10.1371/journal.pone.0225077. eCollection 2020.

引用本文的文献

1
Infective Endocarditis-Predictors of In-Hospital Mortality, 17 Years, Single-Center Experience in Bulgaria.感染性心内膜炎——住院死亡率的预测因素,保加利亚单中心17年经验
Microorganisms. 2024 Sep 21;12(9):1919. doi: 10.3390/microorganisms12091919.
2
Trend in Infective Endocarditis in Bulgaria: Characteristics and Outcome, 17-Years, Single Center Experience.保加利亚感染性心内膜炎的趋势:特征与结局,17年单中心经验
Microorganisms. 2024 Aug 9;12(8):1631. doi: 10.3390/microorganisms12081631.
3
Infective Endocarditis-Characteristics and Prognosis According to the Affected Valves.

本文引用的文献

1
Temporal changes in the incidence of infective endocarditis in Denmark 1997-2017: A nationwide study.1997-2017 年丹麦感染性心内膜炎发病率的时间变化:一项全国性研究。
Int J Cardiol. 2021 Mar 1;326:145-152. doi: 10.1016/j.ijcard.2020.10.029. Epub 2020 Oct 16.
2
Incidence, Microbiology, and Outcomes in Patients Hospitalized With Infective Endocarditis.感染性心内膜炎住院患者的发病率、微生物学和结局。
Circulation. 2020 Jun 23;141(25):2067-2077. doi: 10.1161/CIRCULATIONAHA.119.044913. Epub 2020 May 15.
3
Cardiac surgery in infective endocarditis and predictors of in-hospital mortality.
感染性心内膜炎——根据受累瓣膜的特征及预后
Microorganisms. 2024 May 14;12(5):987. doi: 10.3390/microorganisms12050987.
4
Endocarditis Without Risk Factors: Clinical Awareness Is Key.无危险因素的心内膜炎:临床意识是关键。
Cureus. 2023 Oct 13;15(10):e46988. doi: 10.7759/cureus.46988. eCollection 2023 Oct.
5
Infective endocarditis risk in patients with bicuspid aortic valve: Systematic review and meta-analysis.二叶式主动脉瓣患者感染性心内膜炎的风险:系统评价与荟萃分析
Int J Cardiol Heart Vasc. 2023 Jul 28;47:101249. doi: 10.1016/j.ijcha.2023.101249. eCollection 2023 Aug.
6
Sex-related disparities in the incidence and outcomes of infective endocarditis according to type 2 diabetes mellitus status in Spain, 2016-2020.根据西班牙 2016-2020 年 2 型糖尿病状况,比较感染性心内膜炎发病率和结局的性别差异。
Cardiovasc Diabetol. 2022 Sep 30;21(1):198. doi: 10.1186/s12933-022-01633-2.
7
Surgical Procedure Time and Mortality in Patients with Infective Endocarditis Caused by or Species.由[具体菌种1]或[具体菌种2]引起的感染性心内膜炎患者的手术操作时间和死亡率
J Clin Med. 2022 Apr 30;11(9):2538. doi: 10.3390/jcm11092538.
8
Sex-Specific Risk Factors for Short- and Long-Term Outcomes after Surgery in Patients with Infective Endocarditis.感染性心内膜炎患者手术后短期和长期预后的性别特异性危险因素
J Clin Med. 2022 Mar 28;11(7):1875. doi: 10.3390/jcm11071875.
感染性心内膜炎的心脏手术和院内死亡率的预测因素。
Rev Port Cardiol (Engl Ed). 2020 Mar;39(3):137-149. doi: 10.1016/j.repc.2019.08.009. Epub 2020 Apr 25.
4
Contemporary Trends in Native Valve Infective Endocarditis in United States (from the National Inpatient Sample Database).美国原发性心脏瓣膜感染性心内膜炎的当代趋势(来自全国住院患者样本数据库)。
Am J Cardiol. 2020 Jun 1;125(11):1678-1687. doi: 10.1016/j.amjcard.2020.02.035. Epub 2020 Mar 16.
5
Risk Factors for In-Hospital Mortality in Infective Endocarditis.感染性心内膜炎患者住院期间死亡的危险因素。
Arq Bras Cardiol. 2020 Jan;114(1):1-8. doi: 10.36660/abc.20180194.
6
Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study.感染性心内膜炎的临床表现、病因和结局。ESC-EORP EURO-ENDO(欧洲感染性心内膜炎)注册研究的结果:一项前瞻性队列研究。
Eur Heart J. 2019 Oct 14;40(39):3222-3232. doi: 10.1093/eurheartj/ehz620.
7
[Infective endocarditis. Epidemiology, pathophysiology and histopathology].[感染性心内膜炎。流行病学、病理生理学与组织病理学]
Presse Med. 2019 May;48(5):513-521. doi: 10.1016/j.lpm.2019.04.009. Epub 2019 May 2.
8
Thirty-Day Readmission After Infective Endocarditis: Analysis From a Nationwide Readmission Database.感染性心内膜炎 30 天后再入院:来自全国再入院数据库的分析。
J Am Heart Assoc. 2019 May 7;8(9):e011598. doi: 10.1161/JAHA.118.011598.
9
Infective Endocarditis: Update on Epidemiology, Outcomes, and Management.感染性心内膜炎:流行病学、结局和管理的更新。
Curr Cardiol Rep. 2018 Aug 16;20(10):86. doi: 10.1007/s11886-018-1043-2.
10
Infective endocarditis: Surgical management and prognostic predictors.感染性心内膜炎:外科治疗与预后预测因素
Rev Port Cardiol (Engl Ed). 2018 May;37(5):387-394. doi: 10.1016/j.repc.2017.08.007. Epub 2018 May 3.